Bill

Bill > S179


NJ S179

NJ S179
Requires physician to offer to test patient for dihydropyrimidine dehydrogenase deficiency prior to patient undergoing chemotherapy.


summary

Introduced
01/14/2020
In Committee
01/14/2020
Crossed Over
Passed
Dead
01/11/2022

Introduced Session

2020-2021 Regular Session

Bill Summary

This bill requires a physician to offer to test a patient for dihydropyrimidine dehydrogenase deficiency prior to the patient undergoing chemotherapy. Dihydropyrimidine dehydrogenase deficiency is a disorder in which the human body experiences difficultly or is unable to breakdown chemotherapy drugs leading to a harmful reaction. Under the bill, health insurance plans in this State are to cover expenses incurred in conducting one test for dihydropyrimidine dehydrogenase deficiency every year.

AI Summary

This bill requires a physician to offer to test a patient for dihydropyrimidine dehydrogenase deficiency, a disorder in which the body has difficulty breaking down chemotherapy drugs, prior to the patient undergoing chemotherapy. The bill also mandates that health insurance plans in the state cover the expenses for one such test per year, as well as any prescription drug treatment for the condition if the policy provides prescription drug benefits. The bill directs the Commissioner of Health and the Department of Banking and Insurance to pass regulations to implement these provisions, and it takes effect 90 days after enactment.

Committee Categories

Health and Social Services

Sponsors (1)

Last Action

Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee (on 01/14/2020)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...